A
$57B drug? Medicare faces a massive bill for Biogen's Aduhelm—even if it
limits coverage
Fierce Pharma
In 2017, about 2 million Medicare beneficiaries used an
Alzheimer's treatment. Aduhelm cost to Medicare. In KFF's
conservative estimate, say just a ...
No comments:
Post a Comment